LAURA LUEBKE: Open Payments
NPI 1669742193 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 29 payments from 13 companies in 2025. Trend: 2023 $745 · 2024 $790 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $211 |
| AstraZeneca Pharmaceuticals LP | 2 | $94 |
| ABBVIE INC. | 3 | $76 |
| Janssen Biotech, Inc. | 2 | $70 |
| Alexion Pharmaceuticals, Inc. | 2 | $47 |
| UCB, Inc. | 1 | $27 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: SAPHNELO, ENBREL, TREMFYA, EVENITY, UPLIZNA, SKYRIZI, ULTOMIRIS, Bimzelx.
Industry payments across AK — which companies pay providers there.
